Covid Vaccines: What’s Going On?
The Covid vaccine is the talk of the town. We’ve all heard about the arguments between the UK and EU over vaccine doses, and Biden’s race for 150 million vaccinations in 100 days. So how is the global community faring with their rollout schemes? Let’s take a whistle stop tour and find out.
Europe: what’s the UK done right, that the EU hasn’t?
For what feels like the first time since the pandemic started, the UK is ahead of the curve, having vaccinated more than 12 million people. Europe, on the other hand, is struggling. Why?
Early preparation: the UK started early. They approved their first vaccine — Pfizer/BioNTech — back on 2nd December, whereas the EU gave approval on 21st December, by which point the UK had already begun vaccinating.
As mentioned in our previous article, anti-vax beliefs hinder vaccination uptake. Tackling this is key. The UK was one of the first to do so, working with social media companies to take down misinformation, and recruiting public figures to share their vaccination experience. Many EU countries are now following suit, for example, Romania has recruited star athletes to spread the pro-vax message.
These factors, early preparation and effective communication to the public, are key to any successful global health campaign.
Across the pond: 150 million vaccinations in 100 days. How’s that looking?
President Biden promised 150 million doses of vaccine in his first 100 days in office (upped from the initial 100 million after criticisms of under-ambition). What’s been done to achieve this?
During the Trump administration, CDC estimations suggest that just over 50% of vaccines distributed to states were ultimately administered. The problem therefore seemed to be poor logistics, rather than vaccine supply. Vaccination centres were not told how many doses to expect in advance, and therefore could not prepare. This was a major problem. To tackle this, the new administration has focused on infrastructure — with guarantees on minimum levels of supply and plans to set up mass vaccination centres over the next weeks.
Will this be enough to achieve 150 million doses? Currently it’s too early to say– around 1.5 million doses per day are needed to achieve his target, but currently doses are lagging behind at 1.3 million per day. Only time will tell if these new strategies will work.
Outside of the Western Hemisphere: where caution and observation dominates
Countries in the Asia-Pacific region have been the pandemic success stories, with few infections and deaths. How are they faring with vaccines? The pace is certainly much slower, with many nations not beginning vaccinations until February or March 2021. New Zealand won’t begin until April 2021. Why is this?
Unlike the US and UK, these countries aren’t struggling with high infection and death rates. The need for vaccination is not as urgent. They can afford to monitor vaccination efficacy and safety, and can wait to negotiate a more reasonable price for the vaccines. This demonstrates the benefits of early, strong intervention during the beginnings of the pandemic.
The downside of vaccine hoarding: lower income countries are missing out
Despite the problems facing Western countries, it is ultimately lower income countries that lose out. Richer countries with only 14% of the world’s population have bought 53% of the global vaccine supply, meaning 90% of people in lower income countries have little chance of getting vaccinated in 2021. What’s being done to help them?
The Covax programme — a collaboration between WHO, World Bank, Unicef and the Bill & Melinda Gates Foundation amongst others — are aiming to distribute 2 billion vaccinations to lower income countries. Problem solved? Unfortunately not. This programme meets only 20% of their vaccine needs. With 70% of the global population requiring immunity to stop Covid-19, further decisive action is needed.
How’s the future looking?
Achieving sufficient vaccination levels is a global task. With new variants emerging globally, it’s a race against time. There’s lots of hope and fantastic biomedical research occurring globally — from promising results of vaccine trials, to research into mixing different vaccines — there’s scope to increase vaccination speed and reach. Only by coordination between countries can we end the disruption of livelihoods and return to normality.
About That Medic Network
If you like this article, be sure to follow us for more content on our Website, Facebook, Twitter, Instagram, LinkedIn.
Feeling friendly or excited for our next article? Email us at info@thatmedicnetwork.com or subscribe to our newsletter.
About the author
Jessy Zhang is a fourth year medical student at University of Cambridge, with interests in healthcare inequality, policy, and mental health. In her free time, she enjoys baking, reading and travelling!
References
- BBC News. Coronavirus: EU demands UK-made AstraZeneca vaccine doses. BBC [Internet]. 2021 Jan 27 [cited 2021 Feb 4]; Available from: https://www.bbc.co.uk/news/world-europe-55822602
- Gallardo C. 8 reasons the UK leads Europe’s coronavirus vaccination race [Internet]. POLITICO. 2021 [cited 2021 Feb 4]. Available from: https://www.politico.eu/article/8-reasons-why-uk-leads-europe-coronavirus-vaccination-race/
- Wolff G. Why has the EU been so slow to roll out a Covid vaccination programme? The guardian [Internet]. 2021 Jan 27 [cited 2021 Feb 4]; Available from: http://www.theguardian.com/commentisfree/2021/jan/27/european-union-slow-covid-vaccination-programme
- BBC News. Biden raises vaccination goal to 1.5m a day after criticism. BBC [Internet]. 2021 Jan 26 [cited 2021 Feb 4]; Available from: https://www.bbc.co.uk/news/world-us-canada-55805428
- Stacey K. Vaccine rollout under Biden struggles to live up to campaign pledge. Financial Times [Internet]. 2021 Feb 1 [cited 2021 Feb 4]; Available from: https://www.ft.com/content/31c6186d-6b76-408b-83f0-a049130fdd7f
- Murphy J, Si W. Biden pledged 150 million Covid vaccinations in 100 days. This is what the numbers say [Internet]. NBC News. 2021 [cited 2021 Feb 4]. Available from: https://www.nbcnews.com/politics/white-house/150-million-vaccinations-tracker-biden-goal-n1255716
- Gunia A. Asia was a model for how to deal with COVID-19. Why is it lagging in vaccine rollouts? Time [Internet]. 2021 Jan 19 [cited 2021 Feb 4]; Available from: https://time.com/5929657/asia-vaccine-rollouts-lagging/
- Dyer O. Covid-19: Many poor countries will see almost no vaccine next year, aid groups warn. BMJ. 2020;371:m4809.
- Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics. Lancet [Internet]. 2021; Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00242-7/fulltext
- BBC News. Covid trial in UK examines mixing different vaccines. BBC [Internet]. 2021 Feb 4 [cited 2021 Feb 4]; Available from: https://www.bbc.co.uk/news/health-55924433